Abstract
Get full access to this article
View all access options for this article.
References
1.
Steinberg
W.
The clinical utility of the CA 19-9 tumor-associated antigen. Am J Gastroenterol 1990 ; 85 : 350 –5 .
2.
Mann
D.V.
,
Edwards
R.
,
Ho
S.
Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice. Eur J Surg Oncol 2000 ; 26 : 474 –9 .
3.
Marcouizos
G.
,
Ignatiadou
E.
,
Papanikolaou
G.E.
Highly elevated serum levels of CA 19-9 in choledocholithiasis: a case report. Cases J 2009 ; 2 : 6662 .
4.
Sheen-Chen
S.M.
,
Sun
C.K.
,
Liu
Y.W.
Extremely elevated CA 19-9 in acute cholangitis. Dig Dis Sci 2007 ; 52 : 3140 –2 .